Congress keeps the heat on 340B
From the article:
The House Energy and Commerce Oversight Subcommittee will probe Wednesday into how hospitals and health clinics participating in the 340B discount drug program are using the savings they reap. Nonprofit hospitals and safety net providers that serve a disproportionate share of low-income patients get steep discounts on outpatient drugs through the 340B program. Five health system executives who participate in the program will testify.
Read more here!fda health care finance health law policy pharmaceuticals rachel sachs